Novocure.com
Novocure Trials Privacy Policy
…of recipients: Group companies: A list of our group companies can be found at https://www.novocure.com/our-global-community/. These group companies may use the data according to this Privacy Notice for the same… […]
ENGOT-ov50 / INNOVATE-3
…of Tumor Treating Fields (TTFields), delivered by the NovoTTF-200(O) device concomitant with a standard chemotherapy agent paclitaxel, for patients recently diagnosed with recurrent ovarian cancer. This study has completed its enrollment…. […]
METIS
…lung cancer), according to best practice of the treating study physician. Patients might benefit from receiving comprehensive follow up exams every 8 weeks that include some testing not typically included… […]
LUNAR
…addition, all study participants contribute to future patients by providing additional information and data used to assess the efficacy of TTFields. eligibility For the complete list of eligibility criteria please… […]
Novocure Trials’ HIPAA Privacy Policy
…right to request an amendment for as long as the information is kept by us. Any patient request for an amendment to PHI should be directed to 855-281-9301 or support@novocure.com. The… […]
Novocure Trials Terms & Conditions
…which apply to your access and use of this website. By accessing or using this website, you agree to be bound by these Terms and Conditions. If you do not… […]
TRIDENT
…continuous use by patients [Living with TTFields]. TTFields have been approved by the FDA for treatment of adult patients with recurrent and newly diagnosed GBM. What makes the TRIDENT study… […]
Contact Novocure Clinical Trials
[…]
ZL-8301-001
…intended for continuous use by patients [Living with TTFields]. The use of NovoTTF-200T for the treatment of gastric is investigational; it has not been approved for this use. The safety… […]
EF-33
…mark in Europe for the same indications. In addition TTFields have been recently approved as Optune Lua™ (formerly NovoTTF-100L) for malignant pleural mesothelioma by the FDA, in combination with chemotherapy,… […]
PANOVA-3
…cancer site. The device is intended for continuous home use by patients [Living with TTFields]. NovoTTF-200T for the treatment of pancreatic cancer is investigational; it has not been approved by the… […]
KEYNOTE B36
…by patients [Living with TTFields]. NovoTTF-200T for the treatment of non-small cell lung cancer is investigational; it has not been approved by the U.S. Food and Drug Administration (FDA). The safety… […]